Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Evolent Health, Inc. before investing.

In this article, we go over a few key elements for understanding Evolent Health, Inc.’s stock price such as:

• Evolent Health, Inc.’s current stock price and volume
• Why Evolent Health, Inc.’s stock price changed recently
• Upgrades and downgrades for EVH from analysts
• EVH’s stock price momentum as measured by its relative strength

About Evolent Health, Inc. (EVH)

Before we jump into Evolent Health, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Want to learn more about Evolent Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Evolent Health, Inc..

Evolent Health, Inc.’s Stock Price as of Market Close

As of June 03, 2026, 1:31 PM, CST, Evolent Health, Inc.’s stock price was $3.790.

Evolent Health, Inc. is down 4.29% from its previous closing price of $3.960.

During the last market session, Evolent Health, Inc.’s stock traded between $3.745 and $3.960. Currently, there are approximately 111.91 million shares outstanding for Evolent Health, Inc..

Evolent Health, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Evolent Health, Inc. Stock Price History

Evolent Health, Inc.’s (EVH) price is currently down 4.05% so far this month.

During the month of June, Evolent Health, Inc.’s stock price has reached a high of $4.250 and a low of $3.745.

Over the last year, Evolent Health, Inc. has hit prices as high as $12.065 and as low as $2.095. Year to date, Evolent Health, Inc.’s stock is down 5.25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Evolent Health, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 02, 2026, there were 0 analysts who downgraded Evolent Health, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Evolent Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Evolent Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Evolent Health, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Evolent Health, Inc. (EVH) by visiting AAII Stock Evaluator.

Relative Price Strength of Evolent Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 02, 2026, Evolent Health, Inc. has a weighted four-quarter relative price strength of -10.80%, which translates to a Momentum Score of 26 and is considered to be Weak.

Want to learn more about how Evolent Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Evolent Health, Inc. Stock Price: Bottom Line

As of June 3, 2026, Evolent Health, Inc.’s stock price is $3.790, which is down 4.29% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Evolent Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.